EV Biologics, Inc. (YECO)
OTCMKTS · Delayed Price · Currency is USD
0.0808
0.00 (0.00%)
At close: Jul 16, 2025
EV Biologics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2017 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | 2011 - 2012 |
---|---|---|---|---|---|---|
Period Ending | Dec '17 Dec 31, 2017 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 | Jun '15 Jun 30, 2015 | Jun '14 Jun 30, 2014 | 2011 - 2012 |
Cash & Equivalents | 8.39 | 1.81 | 2.73 | 16.47 | 19.73 | Upgrade |
Short-Term Investments | 4.02 | - | - | - | - | Upgrade |
Cash & Short-Term Investments | 12.4 | 1.81 | 2.73 | 16.47 | 19.73 | Upgrade |
Cash Growth | 583.85% | -33.67% | -83.40% | -16.53% | 240.65% | Upgrade |
Accounts Receivable | 1.03 | 4.97 | 5.73 | 9.33 | 5.18 | Upgrade |
Other Receivables | - | 0.02 | 0.02 | - | - | Upgrade |
Receivables | 1.03 | 4.98 | 5.74 | 9.33 | 6.11 | Upgrade |
Inventory | 0.13 | 0.21 | 0.36 | 0.36 | 0.42 | Upgrade |
Prepaid Expenses | 0.11 | 0.08 | 0.11 | 0.37 | 0.07 | Upgrade |
Restricted Cash | - | 0.5 | 0.5 | - | - | Upgrade |
Other Current Assets | 38.38 | 1.33 | 1.21 | 0.3 | 0.41 | Upgrade |
Total Current Assets | 52.05 | 8.91 | 10.66 | 26.84 | 26.75 | Upgrade |
Property, Plant & Equipment | 5.16 | 6.66 | 7.43 | 41.27 | 34.38 | Upgrade |
Other Intangible Assets | 1.75 | 2.07 | 2.16 | 4.91 | 2.83 | Upgrade |
Long-Term Deferred Tax Assets | - | 0.16 | 0.39 | 0.52 | 0.19 | Upgrade |
Other Long-Term Assets | - | 15.49 | 15.8 | 4.06 | 5.4 | Upgrade |
Total Assets | 58.95 | 33.28 | 36.44 | 77.6 | 69.56 | Upgrade |
Accounts Payable | 1.66 | 2.3 | 1.71 | 1.73 | 1.82 | Upgrade |
Accrued Expenses | 0.08 | 0.42 | 0.44 | 0.29 | 0.22 | Upgrade |
Short-Term Debt | 6.47 | 7.04 | 7.64 | 10.56 | 7.93 | Upgrade |
Current Portion of Leases | - | 4.8 | 4.06 | 4.62 | 1.61 | Upgrade |
Current Income Taxes Payable | - | 0.98 | 1.13 | 0.98 | 0.95 | Upgrade |
Current Unearned Revenue | - | 4.45 | 2.57 | - | 0.4 | Upgrade |
Other Current Liabilities | 8.51 | 9.57 | 7.6 | 12.63 | 0.68 | Upgrade |
Total Current Liabilities | 16.72 | 29.56 | 25.15 | 30.81 | 13.62 | Upgrade |
Long-Term Debt | - | - | - | - | 9.8 | Upgrade |
Long-Term Leases | - | - | 0.03 | 0.14 | 0.07 | Upgrade |
Other Long-Term Liabilities | - | - | - | - | 8.42 | Upgrade |
Total Liabilities | 16.72 | 29.56 | 25.18 | 30.95 | 31.91 | Upgrade |
Common Stock | 8.68 | 0 | 0 | 0.01 | 0.01 | Upgrade |
Additional Paid-In Capital | 15.27 | 40.71 | 40.51 | 19.01 | 19.01 | Upgrade |
Retained Earnings | 18.28 | -35.49 | -28.06 | 25.13 | 16.45 | Upgrade |
Comprehensive Income & Other | - | -1.51 | -1.19 | 2.5 | 2.17 | Upgrade |
Shareholders' Equity | 42.23 | 3.72 | 11.26 | 46.65 | 37.65 | Upgrade |
Total Liabilities & Equity | 58.95 | 33.28 | 36.44 | 77.6 | 69.56 | Upgrade |
Total Debt | 6.47 | 11.85 | 11.73 | 15.31 | 19.41 | Upgrade |
Net Cash (Debt) | 5.94 | -10.03 | -9 | 1.16 | 0.32 | Upgrade |
Net Cash Growth | - | - | - | 262.99% | - | Upgrade |
Net Cash Per Share | 2.46 | -4.16 | -3.77 | 0.72 | 0.20 | Upgrade |
Filing Date Shares Outstanding | 27.41 | 2.41 | 2.4 | 1.6 | 1.6 | Upgrade |
Total Common Shares Outstanding | 2.41 | 2.41 | 2.4 | 1.6 | 1.6 | Upgrade |
Working Capital | 35.33 | -20.65 | -14.49 | -3.97 | 13.14 | Upgrade |
Book Value Per Share | 17.52 | 1.54 | 4.69 | 29.16 | 23.53 | Upgrade |
Tangible Book Value | 40.49 | 1.65 | 9.1 | 41.74 | 34.82 | Upgrade |
Tangible Book Value Per Share | 16.79 | 0.69 | 3.79 | 26.09 | 21.76 | Upgrade |
Buildings | - | 24.24 | 24.74 | 17.96 | 8.24 | Upgrade |
Machinery | - | 8.14 | 8.3 | 8.91 | 5.23 | Upgrade |
Construction In Progress | - | 0.02 | 0.01 | 16.89 | 23.96 | Upgrade |
Updated Nov 15, 2017. Source: S&P Global Market Intelligence. Standard template. Financial Sources.